Personalized Liver Ultrasound · 2020. 7. 17. · Liver Ultrasound No ma˚er how identical people...
1
Hepatitis C is a leading cause of liver cancer and liver transplants. 1 About 75% of people with hepatitis C have no symptoms. 2 As a result, hepatocellular carcinoma (HCC) is known as the “silent killer”, with less than 10% survival rate over 5 years. 3 Liver tissue stiffness is associated with disease progression. Acoustic Radiation Force Impulse (ARFI) imaging values quantify and predict tissue stiffness. 4 Mild/No Stiffness Moderate Stiffness High Stiffness years survival rate 2.2 m/s (14.5 kPa) 1.34 m/s (5.4 kPa) Ultrasound shear-wave imaging uses ARFI imaging. It is a quick, non-invasive test that can be performed as part of a routine diagnostic ultrasound. The quantitative stiffness property of liver tissue, an indication for disease, can be obtained with 1 push of a buon. The exam is not painful for the patient and delivers objective results for the sonographer. 1 Viral Hepatitis-CDC Recommendations for Specific Populations and Seings. Centers for Disease Control and Prevention; 2015 May 31 [cited 2017 April 6]. 2 Hepatitis C. U.S. Department of Health and Human Services, Office of Population Affairs. [cited 2017 April 6]. 3 WT London, KA McGlynn: D Schoenfeld JF Fraumeni Jr, Liver Cancer, Cancer Epidemiology and Prevention 763 - 786, 2006 ed 3 New York, NY Oxford University Press [cited 2017 May 9]. 4 Barr, et.al. Elastography Assesment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Statement. Radiology 2015 Sep 16; 276(3):845-61 Published by Siemens Healthcare GmbH · Order No. A91US-504-1C-4A00 · Printed in USA © Siemens Medical Solutions USA, Inc., 2018 When combined with other advanced ultrasound technologies from Siemens Healthineers, a comprehensive picture of liver health can be obtained. The diagnostic approach can be tailored to the needs of each individual patient. Personalized Liver Ultrasound No maer how identical people look, care profiles – like fingerprints – are unique. The right tool should be matched to the right patient at the right time for precise diagnosis and expedient care. Personalized liver ultrasound offers all the necessary advanced ultrasound applications to advance patient care and optimize clinical workflows. Because care should be as unique as your patient’s fingerprint. e S i e F u s i o n I m a g i n g I n t e r v e n e C h a r a c t e r i z e C a d e n c e Co n t r a s t I m a g i n g M o n i t o r V i r t u a l T o u c h Qu a n t i fi c at i o n Delivering customized packages of advanced applications to address your patient’s unique place on the clinical pathway of chronic liver disease. Because care should be as unique as your patient’s fingerprint. Learn more at: www.siemens.com/ultrasound Personalized Liver Ultrasound –
Transcript of Personalized Liver Ultrasound · 2020. 7. 17. · Liver Ultrasound No ma˚er how identical people...
Hepatitis C is a leadingcause of liver cancerand liver transplants.1
About 75% of people with hepatitis C have no symptoms.2
As a result, hepatocellular carcinoma (HCC) is known as the “silent killer”, with less than10% survival rate over 5 years.3 Liver tissue stiffness is associated
with disease progression. Acoustic Radiation Force Impulse (ARFI) imaging values quantify and predict tissue stiffness.4
Mild/NoStiffness
ModerateStiffness
HighStiffness
years survival rate
2.2 m/s(14.5 kPa)
1.34 m/s(5.4 kPa)
Ultrasound shear-wave imaging uses ARFI imaging. It is a quick, non-invasive test that can be performed as part of a routine diagnostic ultrasound.
The quantitative stiffness property of liver tissue, an indication for disease, can be obtained with 1 push of a bu�on. The exam is not painful for the patient and delivers objective results for the sonographer.
1 Viral Hepatitis-CDC Recommendations for Specific Populations and Se�ings. Centers for Disease Control and Prevention; 2015 May 31 [cited 2017 April 6].
2 Hepatitis C. U.S. Department of Health and Human Services, Office of Population Affairs. [cited 2017 April 6].3 WT London, KA McGlynn: D Scho�enfeld JF Fraumeni Jr, Liver Cancer, Cancer Epidemiology and Prevention
763 - 786, 2006 ed 3 New York, NY Oxford University Press [cited 2017 May 9].4 Barr, et.al. Elastography Assesment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Statement.
Radiology 2015 Sep 16; 276(3):845-61
Published by Siemens Healthcare GmbH · Order No. A91US-504-1C-4A00 · Printed in USA© Siemens Medical Solutions USA, Inc., 2018
When combined with other advancedultrasound technologies from Siemens Healthineers, a comprehensivepicture of liver health can be obtained. The diagnostic approach can be tailored to the needs of each individual patient.
PersonalizedLiver Ultrasound
No ma�er how identical people look, care profiles – like fingerprints – are unique. The right tool should be matched to the right patient at the right time for precise diagnosis and expedient care. Personalized liver ultrasound offers all the necessary advanced ultrasound applications to advance patient care and optimize clinical workflows.
Because care should be as unique as your patient’s fingerprint.
eSieFusion Imaging
Intervene
Characterize
Cadence Contrast I maging
Mon
itor
Virt
ual T
ouch
Quantification
Delivering customized packages of advanced applications to address your patient’s unique place on the clinical pathway of chronic liver disease. Because care should be as unique as your patient’s fingerprint.
Learn more at: www.siemens.com/ultrasound
Personalized Liver Ultrasound –
![Endoscopic ultrasound-guided biopsy in chronic liver ...scopic ultrasound-guided liver biopsy (EUS-LB) is another method of acquiring liver tissue [8,9]. The feasibility of EUS-LB](https://static.fdocuments.in/doc/165x107/600c40491939a52c585d9ae9/endoscopic-ultrasound-guided-biopsy-in-chronic-liver-scopic-ultrasound-guided.jpg)
